[go: up one dir, main page]

DE60329931D1 - Fprl1-liganden und deren verwendung - Google Patents

Fprl1-liganden und deren verwendung

Info

Publication number
DE60329931D1
DE60329931D1 DE60329931T DE60329931T DE60329931D1 DE 60329931 D1 DE60329931 D1 DE 60329931D1 DE 60329931 T DE60329931 T DE 60329931T DE 60329931 T DE60329931 T DE 60329931T DE 60329931 D1 DE60329931 D1 DE 60329931D1
Authority
DE
Germany
Prior art keywords
fprl1
seq
amino acid
acid sequence
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60329931T
Other languages
English (en)
Inventor
Shuji Hinuma
Makoto Kobayashi
Yugo Habata
Masataka Harada
Shoichi Okubo
Hiromi Yoshida
Kazunori Nishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60329931D1 publication Critical patent/DE60329931D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60329931T 2002-11-07 2003-11-06 Fprl1-liganden und deren verwendung Expired - Lifetime DE60329931D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002324189 2002-11-07
JP2002367119 2002-12-18
JP2003059073 2003-03-05
JP2003191359 2003-07-03
PCT/JP2003/014138 WO2004041850A1 (ja) 2002-11-07 2003-11-06 新規なfprl1リガンドおよびその用途

Publications (1)

Publication Number Publication Date
DE60329931D1 true DE60329931D1 (de) 2009-12-17

Family

ID=32314929

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60329931T Expired - Lifetime DE60329931D1 (de) 2002-11-07 2003-11-06 Fprl1-liganden und deren verwendung

Country Status (6)

Country Link
US (1) US7943137B2 (de)
EP (1) EP1559721B1 (de)
AT (1) ATE447586T1 (de)
AU (1) AU2003277575A1 (de)
DE (1) DE60329931D1 (de)
WO (1) WO2004041850A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1448600A4 (de) 2001-09-07 2004-12-22 Bristol Myers Squibb Co Für einen neuen menschlichen g-protein-gekoppelten rezeptor hgprbmy39 codierendes polynukleotid
ATE531727T1 (de) * 2006-09-18 2011-11-15 Compugen Ltd Bioaktive peptide und verfahren zu ihrer verwendung
PT2770989T (pt) 2011-10-26 2018-12-04 Allergan Inc Derivados de amida de aminoácidos substituídos por n-ureia como moduladores de recetor tipo-1 do recetor de péptidos formil (fprl-1)
CN105007909B (zh) * 2013-03-06 2019-06-28 阿勒根公司 用于治疗眼部炎性疾病的甲酰基肽受体2激动剂的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2030000A (en) * 1998-11-25 2000-06-13 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
AU2754600A (en) 2000-02-04 2001-08-14 Us Health Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
ATE432985T1 (de) * 2000-03-07 2009-06-15 Japan Tobacco Inc Polypeptide mit aktivität der stimulierung von neutrophilen
US7172876B2 (en) 2002-06-14 2007-02-06 Takeda Pharmaceutical Company Limited Method of screening therapeutic agents for nerve degeneration associated diseases
WO2004008141A1 (ja) 2002-07-15 2004-01-22 Takeda Chemical Industries, Ltd. 新規スクリーニング方法

Also Published As

Publication number Publication date
US7943137B2 (en) 2011-05-17
EP1559721B1 (de) 2009-11-04
EP1559721A1 (de) 2005-08-03
WO2004041850A1 (ja) 2004-05-21
US20070065819A1 (en) 2007-03-22
EP1559721A4 (de) 2006-03-29
AU2003277575A1 (en) 2004-06-07
ATE447586T1 (de) 2009-11-15

Similar Documents

Publication Publication Date Title
DE60332320D1 (de) Neues screening-verfahren
IL176674A0 (en) Fc region variants
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
DE69932738D1 (de) 3-azabicyclo(3.1.0)hexanderivate als opiat rezeptoren liganden
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE60325493D1 (de) Substituierte 1,4-dipiperidin-4-yl-piperazinderivate und deren verwendung als neurokininantagonisten
DE602004006169D1 (de) Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
EP1700120A4 (de) Marker für neuromyelitis optica
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
PT1454992E (pt) Ensaio de quinase do linfoma anaplastico, reagentes e composicoes
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
DE60322613D1 (de) Frostschutzproteine aus Basidiomyceten
IL165031A0 (en) Quality assays for antigen presenting cells
ATE505549T1 (de) Männliche fertilitätvermittelnde nukleotidsequenzen und deren verwendung
DE60329931D1 (de) Fprl1-liganden und deren verwendung
EA200500878A1 (ru) Кальцилитические соединения
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
FR2874483B1 (fr) Procede de gradation automatique d'articles, notamment de vetements
DE602004030899D1 (de) Neues screening-verfahren
ATE511644T1 (de) Neues screening-verfahren
WO2005100386A3 (en) Canine cold-and menthol-sensitive receptor 1
WO2003082320A1 (fr) Nouveau procede de criblage
GEP20084464B (en) Mutated neublastin
DE602004023493D1 (de) Neues screening-verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition